1Adult neurogenesis from reprogrammed astrocytesBrian B. Griffiths, Anvee Bhutani, Creed M. Stary973-9792Astrocytic modulation of potassium under seizuresFushun Wang, Xiaoming Qi, Jun Zhang, Jason H. Huang980-9873Type XIX collagen: a promising biomarker from the basement membranesAna C. Calvo, Laura Moreno, Leticia Moreno, Janne M. Toivonen, Raquel Manzano, Nora Molina, Miriam de la Torre, Tresa López, Francisco J. Miana-Mena, María J. Mu?oz, Pilar Zaragoza, Pilar Larrod, Alberto García-Redondo, Rosario Osta988-9954Heterogeneity in the regenerative abilities of central nervous system axons within species: why do some neurons regenerate better than others?William Rodemer, Jianli Hu, Michael E. Selzer, Michael I. Shifman996-10055Locus coeruleus-norepinephrine: basic functions and insights into Parkinson’s diseaseBilal Abdul Bari, Varun Chokshi, Katharina Schmidt1006-10136Stroke gets in your eyes: stroke-induced retinal ischemia and the potential of stem cell therapyChase Kingsbury, Matt Heyck, Brooke Bonsack, Jea-Young Lee, Cesar V. Borlongan1014-10187Using our mini-brains: cerebral organoids as an improved cellular model for human prion diseaseBradley R. Groveman, Ryan Walters, Cathryn L. Haigh1019-10208Harnessing the stem cell properties of pericytes to repair the brainJo-Maree Courtney, Brad A. Sutherland1021-10229Exosome-mediated crosstalk between microglia and neural stem cells in the repair of brain injuryBo-Ru Hou, Cheng Jiang, Ze-Ning Wang, Hai-Jun Ren1023-102410The extended renin-angiotensin system: a promising target for traumatic brain injury therapeuticsZachary C. Janatpour, Aviva J. Symes1025-102611A human translational model based on neuroplasticity for pharmacological agents potentially effective in Treatment-Resistant Depression:focus on dopaminergic systemGinetta Collo, Emilio Merlo Pich1027-102912Vascular dysfunction in Alzheimer’s disease: a biomarker of disease progression and a potential therapeutic targetKaran Govindpani, Chitra Vinnakota, Henry J. Waldvogel, Richard L. Faull, Andrea Kwakowsky1030-103213Remote ischemic conditioning approach for the treatment of ischemic strokeSeyed Mohammad Seyedsaadat, David F. Kallmes, Waleed Brinjikji1033-103414Abscisic acid, a promising therapeutic molecule to prevent Alzheimer’s and neurodegenerative diseasesAna María Sánchez-Pérez1035-103615Leaky gut, dysbiosis, and enteric glia activation: the trilogy behind the intestinal origin of Parkinson’s diseaseLuisa Seguella, Giovanni Sarnelli, Giuseppe Esposito1037-103816Orexin/hypocretinin in multiple sclerosis and experimental autoimmune encephalomyelitisJean Pierre Pallais, Catherine M. Kotz, Milos Stanojlovic1039-104017Novel small molecule TRVA242 targets neuromuscular junction in amyotrophic lateral sclerosisPoulomee Bose1041-104218Human endogenous retroviruses:ammunition for myeloid cells in neurodegenerative diseases?Joel Gruchot, David Kremer, Patrick Küry1043-104419Modified constraint-induced movement therapy alters synaptic plasticity of rat contralateral hippocampus following middle cerebral artery occlusionBei-Yao Gao, Dong-Sheng Xu, Pei-Le Liu, Ce Li, Liang Du, Yan Hua, Jian Hu, Jia-Yun Hou, Yu-Long Bai1045-105720A mimetic peptide of α2,6-sialyllactose promotes neuritogenesisShuang-Xi Chen, Jia-Hui He, Yong-Jian Mi, Hui-Fan Shen, Melitta Schachner, Wei-Jiang Zhao1058-1065 